1. Home
  2. WAFU vs DRMA Comparison

WAFU vs DRMA Comparison

Compare WAFU & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WAFU

Wah Fu Education Group Limited

HOLD

Current Price

$1.49

Market Cap

5.8M

Sector

Real Estate

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.16

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFU
DRMA
Founded
1999
2014
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.6M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
WAFU
DRMA
Price
$1.49
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 317.1K
33.1K
Earning Date
07-31-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.95
52 Week High
$3.06
$5.87

Technical Indicators

Market Signals
Indicator
WAFU
DRMA
Relative Strength Index (RSI) 55.00 42.03
Support Level $1.30 $1.11
Resistance Level $1.72 $1.40
Average True Range (ATR) 0.12 0.08
MACD 0.02 -0.00
Stochastic Oscillator 27.42 35.76

Price Performance

Historical Comparison
WAFU
DRMA

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: